246 related articles for article (PubMed ID: 27298260)
21. Anti-HIV-1 activity of the G-quadruplex ligand BRACO-19.
Perrone R; Butovskaya E; Daelemans D; Palù G; Pannecouque C; Richter SN
J Antimicrob Chemother; 2014 Dec; 69(12):3248-58. PubMed ID: 25103489
[TBL] [Abstract][Full Text] [Related]
22. Solution structure of the major G-quadruplex formed in the human VEGF promoter in K+: insights into loop interactions of the parallel G-quadruplexes.
Agrawal P; Hatzakis E; Guo K; Carver M; Yang D
Nucleic Acids Res; 2013 Dec; 41(22):10584-92. PubMed ID: 24005038
[TBL] [Abstract][Full Text] [Related]
23. The major G-quadruplex formed in the human BCL-2 proximal promoter adopts a parallel structure with a 13-nt loop in K+ solution.
Agrawal P; Lin C; Mathad RI; Carver M; Yang D
J Am Chem Soc; 2014 Feb; 136(5):1750-3. PubMed ID: 24450880
[TBL] [Abstract][Full Text] [Related]
24. Long-term suppression of HIV-1C virus production in human peripheral blood mononuclear cells by LTR heterochromatization with a short double-stranded RNA.
Singh A; Palanichamy JK; Ramalingam P; Kassab MA; Bhagat M; Andrabi R; Luthra K; Sinha S; Chattopadhyay P
J Antimicrob Chemother; 2014 Feb; 69(2):404-15. PubMed ID: 24022068
[TBL] [Abstract][Full Text] [Related]
25. Solution structures of all parallel-stranded monomeric and dimeric G-quadruplex scaffolds of the human c-kit2 promoter.
Kuryavyi V; Phan AT; Patel DJ
Nucleic Acids Res; 2010 Oct; 38(19):6757-73. PubMed ID: 20566478
[TBL] [Abstract][Full Text] [Related]
26. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.
Pereira LA; Bentley K; Peeters A; Churchill MJ; Deacon NJ
Nucleic Acids Res; 2000 Feb; 28(3):663-8. PubMed ID: 10637316
[TBL] [Abstract][Full Text] [Related]
27. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
[TBL] [Abstract][Full Text] [Related]
28. Mutations of the human cytomegalovirus immediate-early 2 protein defines regions and amino acid motifs important in transactivation of transcription from the HIV-1 LTR promoter.
Yeung KC; Stoltzfus CM; Stinski MF
Virology; 1993 Aug; 195(2):786-92. PubMed ID: 8337845
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of human immunodeficiency virus type 2 and simian immunodeficiency virus promoter activity.
Hiebenthal-Millow K; Pöhlmann S; Münch J; Kirchhoff F
Virology; 2004 Jul; 324(2):501-9. PubMed ID: 15207635
[TBL] [Abstract][Full Text] [Related]
30. NMR solution structure of the major G-quadruplex structure formed in the human BCL2 promoter region.
Dai J; Chen D; Jones RA; Hurley LH; Yang D
Nucleic Acids Res; 2006; 34(18):5133-44. PubMed ID: 16998187
[TBL] [Abstract][Full Text] [Related]
31. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
[TBL] [Abstract][Full Text] [Related]
32. Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat.
Jadlowsky JK; Wong JY; Graham AC; Dobrowolski C; Devor RL; Adams MD; Fujinaga K; Karn J
Mol Cell Biol; 2014 Jun; 34(11):1911-28. PubMed ID: 24636995
[TBL] [Abstract][Full Text] [Related]
33. X-Linked RNA-Binding Motif Protein Modulates HIV-1 Infection of CD4
Ma L; Jiang QA; Sun L; Yang X; Huang H; Jin X; Zhang C; Wang JH
mBio; 2020 Apr; 11(2):. PubMed ID: 32317327
[TBL] [Abstract][Full Text] [Related]
34. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
Chen H; He J; Fong S; Wilcox G; Wood C
J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
[TBL] [Abstract][Full Text] [Related]
35. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
[TBL] [Abstract][Full Text] [Related]
36. Selective targeting of mutually exclusive DNA G-quadruplexes: HIV-1 LTR as paradigmatic model.
Tassinari M; Zuffo M; Nadai M; Pirota V; Sevilla Montalvo AC; Doria F; Freccero M; Richter SN
Nucleic Acids Res; 2020 May; 48(9):4627-4642. PubMed ID: 32282912
[TBL] [Abstract][Full Text] [Related]
37. Structure of a (3+1) hybrid G-quadruplex in the PARP1 promoter.
Sengar A; Vandana JJ; Chambers VS; Di Antonio M; Winnerdy FR; Balasubramanian S; Phan AT
Nucleic Acids Res; 2019 Feb; 47(3):1564-1572. PubMed ID: 30551210
[TBL] [Abstract][Full Text] [Related]
38. Genetic Variability of Long Terminal Repeat Region between HIV-2 Groups Impacts Transcriptional Activity.
Le Hingrat Q; Visseaux B; Bertine M; Chauveau L; Schwartz O; Collin F; Damond F; Matheron S; Descamps D; Charpentier C
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915276
[TBL] [Abstract][Full Text] [Related]
39. Human immunodeficiency virus type 1 (HIV-1) provirus expression and LTR transcription are repressed in NEF-expressing cell lines.
Maitra RK; Ahmad N; Holland SM; Venkatesan S
Virology; 1991 Jun; 182(2):522-33. PubMed ID: 2024488
[TBL] [Abstract][Full Text] [Related]
40. Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals.
Trejbalová K; Kovářová D; Blažková J; Machala L; Jilich D; Weber J; Kučerová D; Vencálek O; Hirsch I; Hejnar J
Clin Epigenetics; 2016; 8():19. PubMed ID: 26900410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
